The China Anti-Cancer Association (CACA) has entered into separate memorandums of understanding (MOUs) with several leading international oncology organizations, significantly expanding its global collaborative network. This series of signings underscores CACA's commitment to fostering international cooperation in cancer research, treatment, and professional education.

The key partners include:

American Association for Cancer Research (AACR): A premier global cancer research organization. This partnership aims to enhance scientific exchange, promote collaborative research initiatives, and facilitate knowledge sharing between Chinese and international cancer researchers.

National Comprehensive Cancer Network (NCCN): A renowned authority in clinical practice guidelines. Collaboration with NCCN focuses on the adaptation and implementation of high-quality, evidence-based cancer treatment guidelines to improve clinical care standards in China.

Comprehensive Oncology Center of the University Hospital Olomouc (Czech Republic): This agreement strengthens clinical and academic ties with a leading European oncology center, likely involving exchanges in specialized treatment techniques, patient care models, and medical training.

Association of Oncologists of Uzbekistan (AOUZ): This MOU aims to deepen bilateral cooperation in Central Asia, focusing on capacity building, specialist training, and sharing experiences in cancer prevention and control within the region.

The collective goal of these partnerships is to advance the global fight against cancer by promoting multilateral exchange, collaborative research, standardization of treatment protocols, and the cultivation of oncology talent. This moves CACA's strategy beyond bilateral cooperation towards establishing a multifaceted international alliance, aiming to integrate Chinese Oncology more deeply into the global community and contribute to worldwide cancer control efforts.